Skip to main content
SANTEN PHARMACEUTICAL CO.,LTD. logo

SANTEN PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4536 ISIN · JP3336000009 LEI · 529900TPT3I7C17MIM03 T Manufacturing
Open in API
Filings indexed 78 across all filing types
Latest filing 2020-02-07 Interim / Quarterly Rep…
Country JP Japan
Listing T 4536

About SANTEN PHARMACEUTICAL CO.,LTD.

https://www.santen.com/en

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Recent filings

Filing Released Lang Actions
四半期報告書－第108期第3四半期(令和1年10月1日－令和1年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a '第３四半期報告書' (Third Quarter Report) for Santen Pharmaceutical Co., Ltd. It contains detailed financial statements, management analysis of financial conditions, and operating results for the period from April 1, 2019, to December 31, 2019. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-02-07 Japanese
四半期報告書－第108期第2四半期(2019/07/01－2019/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Santen Pharmaceutical Co., Ltd., covering the period from July 1, 2019, to September 30, 2019. It contains detailed financial statements, management analysis (MDA), and operational performance data. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year that contains actual financial statements is classified as an Interim/Quarterly Report (IR). H1 2020
2019-11-08 Japanese
四半期報告書－第108期第1四半期(2019/04/01－2019/06/30)
Interim / Quarterly Report
2019-08-02 Japanese
有価証券報告書－第107期(平成30年4月1日－平成31年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of the US 10-K annual report. It contains the standard cover page (Hyoshi) for such filings, identifying the company (Santen Pharmaceutical), the fiscal year (107th term, 2018-04-01 to 2019-03-31), and the regulatory submission to the Kanto Local Finance Bureau. It is a comprehensive annual financial disclosure document. FY 2019
2019-06-25 Japanese
四半期報告書－第107期第3四半期(2018/10/01－2018/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Santen Pharmaceutical Co., Ltd., covering the third quarter of the 107th fiscal period (October 1, 2018, to December 31, 2018). It contains detailed financial statements, management analysis, and audit information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-02-08 Japanese
四半期報告書－第107期第2四半期(2018/07/01－2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Santen Pharmaceutical Co., Ltd., covering the period from July 1, 2018, to September 30, 2018. It contains detailed financial statements, management analysis (MDA), and corporate information, which is consistent with the definition of an Interim/Quarterly Report (IR). Q2 2018
2018-11-09 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.